Bitcoin at a Key Level – Hold or Break?
| | | |

Bitcoin at a Key Level – Hold or Break?

Bitcoin is currently sitting at a major monthly support zone. This is not just any level…It’s a level that has previously acted as a strong base,and now it’s being tested again. From a structural point of view:Price is reacting from a well-defined demand zone on the right chart. At the same time, when we zoom…

Bitcoin Q2 Outlook: More Pain to Come Before the Cycle Bottoms?
| | | |

Bitcoin Q2 Outlook: More Pain to Come Before the Cycle Bottoms?

We update our quarterly outlook for and highlight relevant fundamental and technical trends that will drive Bitcoin as it muddles through a weak point in the 4-year cycle. Bitcoin Key Points The historically-reliable 4-year halving cycle suggests that Bitcoin’s current bear market may stretch through Q3 before forming a durable bottom. Other measures, including valuations,…

Crypto: A Rebound Amid Extreme Fear
| | | |

Crypto: A Rebound Amid Extreme Fear

Market Overview The crypto market capitalisation has increased by 1.3% to $2.35T over the past 24 hours, recovering to last Friday’s levels. This time, cryptocurrencies struggled to keep pace with equities, where technical oversold conditions, quarterly rebalancing, and positive signals regarding the US-Iran conflict coincided. stands out as the day’s leader, gaining over 22% amidst…

Duolingo Shares Drop Sharply on Disappointing Forward Guidance
| | | |

Duolingo Shares Drop Sharply on Disappointing Forward Guidance

Duolingo Inc. (NASDAQ: DUOL) reported quarterly earnings that surpassed Wall Street expectations, yet the language-learning platform saw its shares tumble nearly 15% after issuing forward guidance that fell short of analyst forecasts. The sharp decline reflected investor concerns that near-term growth may moderate even as the company continues to expand its user base and improve…

Barclays Raises Hims & Hers Price Target to $29!
| | | |

Barclays Raises Hims & Hers Price Target to $29!

Barclays analyst Glen Santangelo has increased the firm’s price target on Hims & Hers Health Inc. (NYSE: HIMS) to $29 from $25, while maintaining an Overweight rating on the shares. In a research note to investors, Santangelo explained that the recent rally in Hims & Hers stock—sparked by the company’s new agreement with Novo Nordisk—highlights…

The Kiwi Bird Diving?
| | | |

The Kiwi Bird Diving?

Over the past year, I’ve been watching the AUD/NZD cross like a hawk – and the story has been pretty clear: the New Zealand Dollar (NZD) has taken a noticeable hit against its Aussie neighbour. If you’re dealing with cross-Tasman business like we are, this move has real implications. We have strong business partners in Australia, and honestly, it…

C3.ai (AI): Buy, Sell, or Hold Following Q4 Earnings?
| | | |

C3.ai (AI): Buy, Sell, or Hold Following Q4 Earnings?

The past six months have been exceptionally challenging for C3.ai (NYSE: AI), a provider of enterprise artificial intelligence software. The stock has declined by 41% over this period, currently trading at $9.21 per share—a sharp pullback that has left many shareholders reassessing their positions. The downturn was precipitated in part by the company’s softer-than-expected quarterly…

SPX – Potential Bearish Retest
| | | |

SPX – Potential Bearish Retest

Following today’s de-escalation headlines, price has rallied back up to the key yellow line which was the critical support level outlined in my last post (“First Target”): This level is not to be taken lightly. In my post prior to the last, I outlined how this would be a key level that would come into…

End of content

End of content